Literature DB >> 16753027

RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.

Masaru Ishii1, Kaori Iwai, Masato Koike, Shiro Ohshima, Eriko Kudo-Tanaka, Taeko Ishii, Toru Mima, Yoshinori Katada, Kunio Miyatake, Yasuo Uchiyama, Yukihiko Saeki.   

Abstract

UNLABELLED: We showed that CD9, a member of tetraspanin superfamily proteins, is expressed in a specific membrane microdomain, called "lipid raft," and is crucial for cell fusion during osteoclastogenesis after activation of the RANK/RANKL system.
INTRODUCTION: Osteoclasts are bone-resorbing multinuclear polykaryons that are essential for bone remodeling and are formed through cell fusion of mononuclear macrophage/monocyte lineage precursors. Although osteoclastogenesis has been shown to be critically regulated by the RANK/RANKL system, the mechanism how precursor cells fuse with each other remains unclear. We examined the function of CD9, a member of tetraspanin superfamily, which has previously been shown to form macromolecular membrane microdomains and to regulate cell-cell fusion in various cell types.
MATERIALS AND METHODS: We used RAW264.7, a macrophage/monocyte lineage cell line, which can differentiate into osteoclast-like polykaryons on the application of RANKL. Expression and distribution of CD9 was assessed by Western blotting, fluorescence-assorted cell sorting (FACS) and immunohistochemistry with light and electron microscopy. A specific neutralizing antibody and RNA interference were used to inhibit the function of CD9, and green fluorescent protein (GFP)-CD9 was exogenously expressed to enhance the effect of CD9. The distribution of CD9 in lipid microdomain was examined by biochemical (sucrose density gradient) isolation and imaging technique.
RESULTS: CD9 is expressed on cell surfaces of RAW264.7, which is enhanced by RANKL. Targeted inhibition of CD9 decreases the number of osteoclast-like cells. On the other hand, overexpression of CD9 promotes spontaneous cell fusion even in the absence of RANKL. CD9 is localized in detergent-insoluble "lipid raft" microdomain in RANKL stimulation, and disruption of lipid rafts markedly reduces the formation of osteoclast-like polykaryons. Immunohistochemical studies of bone tissues revealed the expression of CD9 in osteoclasts in vivo.
CONCLUSIONS: These data suggest that function of tetraspanin CD9 and its expression in lipid rafts are crucial for cell fusion during osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16753027     DOI: 10.1359/jbmr.060308

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  39 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

3.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

Review 4.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

5.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

Review 6.  Role of NADPH oxidase in formation and function of multinucleated giant cells.

Authors:  Mark T Quinn; Igor A Schepetkin
Journal:  J Innate Immun       Date:  2009-07-07       Impact factor: 7.349

7.  Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro.

Authors:  Jian Zhou; Toshifumi Fujiwara; Shiqiao Ye; Xiaolin Li; Haibo Zhao
Journal:  Calcif Tissue Int       Date:  2014-06-17       Impact factor: 4.333

8.  Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model.

Authors:  Taisuke Furuta; Shigeru Miyaki; Hiroyuki Ishitobi; Toshihiko Ogura; Yoshio Kato; Naosuke Kamei; Kenji Miyado; Yukihito Higashi; Mitsuo Ochi
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

9.  Abundant expression of tetraspanin CD9 in activated osteoclasts in ovariectomy-induced osteoporosis and in bone erosions of collagen-induced arthritis.

Authors:  Kaori Iwai; Masaru Ishii; Shiro Ohshima; Kunio Miyatake; Yukihiko Saeki
Journal:  Rheumatol Int       Date:  2007-07-28       Impact factor: 2.631

10.  Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis.

Authors:  Masaru Ishii; Jackson G Egen; Frederick Klauschen; Martin Meier-Schellersheim; Yukihiko Saeki; Jean Vacher; Richard L Proia; Ronald N Germain
Journal:  Nature       Date:  2009-02-08       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.